Industry news

• Enhancing spectroscopy analysis with machine learning

  03 February 2025 Catherine Eckford / European Pharmaceutical Review

  The spectroscopy-based study highlights the importance of integrating data-driven approaches to enhance isomer discrimination.

• The production of new Russian “super antibiotic” to begin in Novosibirsk

  03 February 2025 GxP news

  The Vorozhtsov Novosibirsk Institute of Organic Chemistryis launching the preparatory phase for the production of an innovative antibiotic, Fluorothiazinone, developed by researchers at the Gamaleya National Research Center for Epidemiology and Microbiology. According to Pavel Zaikin, head of the Institute’s Engineering Center, they are already manufacturing the drug’s key component.

• A Russian company has started producing 4 veterinary vaccines

  31 January 2025 GxP news

  A Russian enterprise has launched the production of four veterinary vaccines. The federal state enterprise “Shchelkovo Biochemical Plant” has expanded its range of domestic veterinary drugs by starting the production of several vaccines for livestock. 

• The government held its first meeting on the “New technologies for preserving health” project

  31 January 2025 GxP news

  At the first meeting of the project committee for the national project “New Health Preservation Technologies,” chaired by Deputy Prime Minister Tatyana Golikova, key areas for state support of medical innovations were identified. The government plans to invest in the development of advanced methods for diagnosing biological age and technologies for slowing cellular aging.

• Enhancing spectroscopy analysis with machine learning

  30 January 2025 Catherine Eckford / European Pharmaceutical Review

  The spectroscopy-based study highlights the importance of integrating data-driven approaches to enhance isomer discrimination.

• A device for chronic pain relief has been registered in Russia

  30 January 2025 GxP news

  Motorika Nemo has completed the registration procedure for a spinal cord stimulation (SCS) device complex from the Chinese manufacturer Rishena. The complex includes an implantable stimulator, a programmer-charger, an external test stimulator, and a specialized electrode with accessories.

• East Asians underrepresented in biopharma C-suites: report

  29 January 2025 Darren Incorvaia / FierceBiotech

  Despite making up a sizable chunk of entry-level employees at the biggest U.S. biopharmas, the share of east Asian Americans drops dramatically as you move up the ranks. That’s according to a report from ElevAAte Biotech, a new nonprofit that seeks to boost the biopharma C-suite representation of Americans who come from countries like China, Japan, South Korea and Taiwan.

• Russia to begin testing individual mRNA vaccines against cancer in September

  29 January 2025 GxP news

  In September 2025, the Russian personalized mRNA vaccine will be used in an experimental mode. The Ministry of Health’s permission is expected in August, but the plan is still awaiting approval.

• Biologic demonstrates “tremendous” potential advance in atrial fibrillation

  28 January 2025 Catherine Eckford / European Pharmaceutical Review

  The Phase II study validated an “incredibly safe bleeding profile” for Factor XI inhibitors as a treatment for the common cardiovascular condition.

• The number of veterinary drug importers has risen by 38% since labeling began

  28 January 2025 GxP news

  Following the implementation of the mandatory labeling system for veterinary drugs in Russia, there has been a notable rise in the number of companies engaged in import activities, according to Revaz Yusupov, Deputy General Director of the Center for the Development of Advanced Technologies (CRPT), which operates the digital labeling system “Honest Sign.”